KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medtronic (MDT) Gains from Investment Securities (2016 - 2026)

Medtronic's Gains from Investment Securities history spans 12 years, with the latest figure at -$1.7 billion for Q1 2026.

  • For Q1 2026, Gains from Investment Securities fell 1594.64% year-over-year to -$1.7 billion; the TTM value through Jan 2026 reached $1.4 billion, down 9.51%, while the annual FY2025 figure was $1.8 billion, 12.15% up from the prior year.
  • Gains from Investment Securities for Q1 2026 was -$1.7 billion at Medtronic, down from $1.3 billion in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.7 billion in Q2 2025 and bottomed at -$1.7 billion in Q1 2026.
  • The 5-year median for Gains from Investment Securities is $102.0 million (2022), against an average of $157.3 million.
  • The largest YoY upside for Gains from Investment Securities was 1120.59% in 2023 against a maximum downside of 3343.48% in 2023.
  • A 5-year view of Gains from Investment Securities shows it stood at $102.0 million in 2022, then soared by 1120.59% to $1.2 billion in 2023, then crashed by 131.73% to -$395.0 million in 2024, then surged by 421.27% to $1.3 billion in 2025, then tumbled by 231.91% to -$1.7 billion in 2026.
  • Per Business Quant, the three most recent readings for MDT's Gains from Investment Securities are -$1.7 billion (Q1 2026), $1.3 billion (Q4 2025), and $125.0 million (Q3 2025).